Breast cancer is a heterogeneous disease. The traditional classification uses morphology to divide tumours into distinct categories with differing prognosis and behavior. Despite providing high quality data cheaply, it has limitations and hence there has been a hope that the new molecular methods may help to refine the classification systems. Much has been learned in the last few years however, the molecular taxonomy is still in evolution and likely to change over the coming years. Whether the molecular classification is as useful for special subtypes of breast cancers as it has been for ductal carcinoma, no special type, remains to be determined
Breast cancer is a complex disease, with heterogeneous presentations and clinical courses. Standard ...
Abstract Molecular classification has added important knowledge to breast cancer biology, but has ye...
Breast cancer is the most frequent and the most deadly cancer in women in Western countries. Differe...
Breast carcinoma comprises a group of diseases with specific clinical, histopathologic and molecular...
Breast carcinoma comprises a group of diseases with specific clinical, histopathologic and molecular...
Breast carcinoma comprises a group of diseases with specific clinical, histopathologic and molecular...
Breast cancer is a complex, multifaceted disease encompassing a great variety of entities that show ...
Morphologically identical breast cancers can display divergent clinical outcomes and responses to th...
Breast cancer is a heterogeneous disease featuring distinct histological, molecular and clinical phe...
International audienceThe current histoclinical breast cancer classification is simple but imprecise...
International audienceThe current histoclinical breast cancer classification is simple but imprecise...
International audienceThe current histoclinical breast cancer classification is simple but imprecise...
Breast cancer complexity has long been known and investigated. After a first classification of the d...
In the research studies conducted for the analysis and classification of breast tumors, DNA microass...
International audienceThe current histoclinical breast cancer classification is simple but imprecise...
Breast cancer is a complex disease, with heterogeneous presentations and clinical courses. Standard ...
Abstract Molecular classification has added important knowledge to breast cancer biology, but has ye...
Breast cancer is the most frequent and the most deadly cancer in women in Western countries. Differe...
Breast carcinoma comprises a group of diseases with specific clinical, histopathologic and molecular...
Breast carcinoma comprises a group of diseases with specific clinical, histopathologic and molecular...
Breast carcinoma comprises a group of diseases with specific clinical, histopathologic and molecular...
Breast cancer is a complex, multifaceted disease encompassing a great variety of entities that show ...
Morphologically identical breast cancers can display divergent clinical outcomes and responses to th...
Breast cancer is a heterogeneous disease featuring distinct histological, molecular and clinical phe...
International audienceThe current histoclinical breast cancer classification is simple but imprecise...
International audienceThe current histoclinical breast cancer classification is simple but imprecise...
International audienceThe current histoclinical breast cancer classification is simple but imprecise...
Breast cancer complexity has long been known and investigated. After a first classification of the d...
In the research studies conducted for the analysis and classification of breast tumors, DNA microass...
International audienceThe current histoclinical breast cancer classification is simple but imprecise...
Breast cancer is a complex disease, with heterogeneous presentations and clinical courses. Standard ...
Abstract Molecular classification has added important knowledge to breast cancer biology, but has ye...
Breast cancer is the most frequent and the most deadly cancer in women in Western countries. Differe...